Showing results (61-70 of 285) with videos related to
Sort By:
Pageof 29
International Journal of Molecular Sciences|September 28, 2023
Hepatocellular Carcinoma Prevention in the Era of Hepatitis C EliminationJeffrey V Lazarus, Camila A Picchio, Massimo ColomboSeminars in Liver Disease|June 6, 2018
Management of HCV-Related Liver Disease in Hemophilia and ThalassemiaMaria Grazia Rumi, Vito Di Marco, Massimo ColomboJournal of Hepato-Biliary-Pancreatic Surgery|September 25, 2003
Treatment of chronic hepatitis C in EuropeMassimo Colombo, Maria Grazia Rumi, Ersilio Del NinnoJournal of Medical Virology|July 13, 2002
Recent progress and new trends in the treatment of hepatitis BAlfredo Alberti, Maurizia Rossana Brunetto, Massimo Colombo, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 25, 2020
Elimination of hepatitis C in Europe: can WHO targets be achieved?M Matičič, Andrea Lombardi, Mario U Mondelli, et al.Clinics in Liver Disease|May 16, 2026
Special Populations: Hepatocellular Carcinoma Risk and Liver TransplantationRobert J Wong, Massimo Colombo, Elisa Pinto, et al.Expert Opinion on Biological Therapy|December 23, 2011
Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical managementMauro Viganò, Elisabetta Degasperi, Alessio Aghemo, et al.Thrombosis Research|October 20, 2006
Endothelial protein C receptor plasma levels increase in chronic liver disease, while thrombomodulin plasma levels increase only in hepatocellular carcinomaEugenia Biguzzi, Franca Franchi, Paolo Bucciarelli, et al.Seminars in Liver Disease|February 29, 2020
Postsustained Virological Response Management in Hepatitis C PatientsChiara Masetti, Ana Lleo, Matteo Colombo, et al.Expert Review of Anti-Infective Therapy|May 1, 2013
PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year historyElisabetta Degasperi, Mauro Viganò, Alessio Aghemo, et al.Pageof 29